The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Sep. 16, 2025

Filed:

May. 20, 2020
Applicant:

Douglas Pharmaceuticals Limited, Auckland, NZ;

Inventors:

Ian Hampson, Manchester Greater Manchester, GB;

Lynne Hampson, Manchester Greater Manchester, GB;

Fergus Cameron Binnie, Auckland, NZ;

Peter Surman, Auckland, NZ;

Assignee:
Attorneys:
Primary Examiner:
Assistant Examiner:
Int. Cl.
CPC ...
A61K 47/44 (2017.01); A61K 9/00 (2006.01); A61K 9/06 (2006.01); A61K 9/107 (2006.01); A61K 31/425 (2006.01); A61K 31/505 (2006.01); A61K 45/06 (2006.01); A61P 31/22 (2006.01);
U.S. Cl.
CPC ...
A61K 47/44 (2013.01); A61K 9/0014 (2013.01); A61K 9/0031 (2013.01); A61K 9/0034 (2013.01); A61K 9/06 (2013.01); A61K 9/107 (2013.01); A61K 31/425 (2013.01); A61K 31/505 (2013.01); A61K 45/06 (2013.01); A61P 31/22 (2018.01); A61K 2300/00 (2013.01);
Abstract

Provided herein are methods and compositions for treating and/or inhibiting the development or progression of conditions caused by, or associated with, Herpes Simplex Virus (HSV) infection. In particular, provided are compositions comprising lopinavir alone, or lopinavir and ritonavir, methods for their manufacture; and the use of said pharmaceutical compositions as a medicament. In particular, pharmaceutical compositions are provided for use in treating and/or inhibiting the progression of HSV related conditions.


Find Patent Forward Citations

Loading…